Cognitive & Nootropic
Semax
A synthetic heptapeptide based on an ACTH(4-10) fragment with a stabilizing C-terminal extension, developed in Russia. Studied as a nootropic/neuroprotective research compound with proposed effects on BDNF/NGF expression and dopaminergic/serotonergic signaling; typically intranasal.
Third party tested
Independent lab verified
≥98% purity
HPLC verified per batch
COA included
Every batch documented
Ships from U.S.A.
Fast & discreet packaging
Strength
$58per vial
Subtotal: $58
Quantity
1
Verified
Batch testing & COAs
No batches published yet.
Related
